Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.73 |
| ▸ | MAPT | P10636 | 6/20 | 0.70 |
| ▸ | MEN1 | O00255 | 4/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.70 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.70 |
| ▸ | POLB | P06746 | 1/20 | 0.70 |
| ▸ | RAB9A | P51151 | 5/20 | 0.68 |
| ▸ | NPC1 | O15118 | 4/20 | 0.68 |
| ▸ | LMNA | P02545 | 4/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.66 |
| ▸ | GAA | P10253 | 1/20 | 0.62 |
| ▸ | TERT | O14746 | 2/20 | 0.59 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.59 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.59 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.57 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1913977 | 0.88 | ALDH1A1 (0.73) | CYP1A2MAPTMEN1KMT2AL3MBTL1 | |
| Hydrochloric Acid SCHEMBL4188904 | 0.86 | ALDH1A1 (0.71) | CYP1A2MAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL13990189 | 0.85 | CYP1A2 (1.00) | CYP1A2MAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL21294247 | 0.85 | SMN1; SMN2 (0.80) | CYP1A2MAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL31036037 | 0.85 | SMN1; SMN2 (0.80) | CYP1A2MAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL521958 | 0.82 | MAPT (1.00) | CYP1A2MAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL11710607 | 0.82 | MAPT (0.74) | CYP1A2MAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL11710601 | 0.82 | MEN1 (0.74) | CYP1A2MAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL28549583 | 0.82 | CYP1A2 (0.72) | CYP1A2MAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL28931481 | 0.82 | RAB9A (0.91) | CYP1A2MAPTMEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101631874-B | Medium for the detection and/or identification of bacteria | BIOMERIEUX SA FR | 2014-11-12 | — | — | CN | disclosed |
| US-8216802-B2 | Detection medium for gram negative bacteria | BIOMERIEUX (FR) | 2012-07-10 | — | — | US | disclosed |
| US-7799810-B2 | Organic compounds | NOVARTIS AG (CH) | 2010-09-21 | — | — | US | disclosed |
| US-20100120865-A1 | Organic compounds | NOVARTIS AG (CH) | 2010-05-13 | — | — | US | disclosed |
| US-20100062466-A1 | MEDIUM FOR THE DETECTION AND/OR IDENTIFICATION OF BACTERIA | BIOMERIEUX (FR) | 2010-03-11 | — | — | US | disclosed |
| CN-101631874-A | Be used to detect and/or differentiate the medium of bacterium | BIOMERIEUX SA | 2010-01-20 | — | — | CN | disclosed |
| EP-2035413-A2 | THIAZOLYL UREA DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | Novartis AG (CH) | 2009-03-18 | — | — | EP | disclosed |
| WO-2008000421-A2 | THIAZOLYL UREA DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | NOVARTIS AG (CH) | 2008-01-03 | — | — | WO | disclosed |
| CN-1262671-C | Novel enzyme substrates for the detection of Pseudomonas aeruginosa, compositions containing them, and methods for detecting this species | BIOMERIEUX SA (FR) | 2006-07-05 | — | — | CN | disclosed |
| CN-1408026-A | Novel enzyme substrates for the detection of Pseudomonas aeruginosa, compositions containing them, and methods for detecting this species | BIOMERIEUX SA (FR) | 2003-04-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100120865-A1 | Organic compounds | PIK3C3, PIK3R3, PIK3R4 | CYP1A2 1839/4885MAPT 1655/4885MEN1 2513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.